.
MergerLinks Header Logo

New Deal

New Deal

Announced

Completed

Medifarma completed the acquisition of Hersil for $160m.

Financials

Edit Data
Transaction Value£132m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
HERSIL

target

HERSIL

MEDIFARMA

bidder

MEDIFARMA

Sources

Edit

Tags

Edit

Peru

Pharmaceutical lab

Pharmaceuticals

Acquisition

Majority

Private

Domestic

Completed

Friendly

Single Bidder

Synopsis

Edit

Medifarma, a pharmaceutical company, completed the acquisition of Hersil, a Peruvian pharmaceutical laboratory, for $160m.

Service Providers

Dealmakers (3)

Sebastian F Baquiran

Sebastian F Baquiran

President Director at MEDIFARMA
Deal Bio
Total Deals
1/
Total Value
£132M
Alejandro Gonzalez Lazzeri

Alejandro Gonzalez Lazzeri

Partner at Skadden Arps Slate Meagher & Flom
Deal Bio
Total Deals
8/
Total Value
£1,423M
Nicolas Perez – Sierra

Nicolas Perez – Sierra

Counsel at Skadden Arps Slate Meagher & Flom
Deal Bio
Total Deals
6/
Total Value
£617M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US